MOH — authorised 18 December 2013
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: likely_approved
🇮🇱 Incruse Ellipta in Israel
MOH authorised Incruse Ellipta on 18 December 2013
Marketing authorisation
Incruse Ellipta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Israel
Frequently asked questions
Is Incruse Ellipta approved in Israel?
Yes. MOH authorised it on 18 December 2013.
Who is the marketing authorisation holder for Incruse Ellipta in Israel?
GLAXOSMITHKLINE holds the Israeli marketing authorisation.